|
|
|
|
Aberrant DNA methylation of imprinted H19 gene in human preimplantation embryos - Corrected Proof
DNA methylation patterns of the H19 differentially methylated region were successfully determined in 32 of 50 human day 3 embryos produced and discarded after assisted reproductive technology procedures.Aberrant DNA methylation of imprinted...
|
|
|
Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing
Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation.A global leader for...
|
|
|
Dinitroaniline Activity in Toxoplasma gondii Expressing Wild-Type or Mutant -Tubulin
The human parasite Toxoplasma gondii is sensitive to dinitroaniline compounds which selectively disrupt microtubules in diverse protozoa but which have no detectable effect on vertebrate host cell microtubules or other functions.Replication of wild-type T.
|
|
|
Manufacturing news in brief
Developments in the pharmaceutical manufacturing arena in the last week include facility news for Dr Reddy's, Dishman, W.Grace, Haselmeier and Fresenius Kabi, first-quarter results for Patheon and a new contract for Angel Biotech of the UK. UK contract...
|
|
|
PHR1 is a vesicle-bound protein abundantly expressed in mature olfactory neurons
To characterize the role of Phr1, a gene highly expressed in primary sensory neurons where it encodes an integral membrane protein with an N-terminal pleckstrin homology domain and a C-terminal transmembrane domain, in the olfactory system.We studied the...
|
|
|
Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia
Leukemia advance online publication, March 18, 2010.doi:10.1038/leu.2010. Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.
|
|
|
Therapeutic Potential
Scientists Scrutinize Promising Molecules as Potential Drug Targets and Biomarkers Patricia F.Dimond, Ph. click to enlarge Researchers at Mt. Sinai School of Medicine are using artificial miRNA target sites to exploit or modulate endogenous miRNA...
|
|
|
New Predictive ADME/Tox Strategies Reduce Attrition
Susan Aldridge, Ph.click to enlarge The formation of data-sharing consortia between big pharma companies and academia has helped decrease attrition. (UCB Pharma) Predictive toxicology tools and safety strategies put in place earlier in the drug-development...
|
|
|
Ambry to Offer Sequence-Enrichment Capabilities with RainDances RDT1000 Platform
Molecular Diagnostics GEN News Highlights GEN News Highlights Ambry Geneticsand RainDance Technologies are partnering to offer diagnostics and genomics services utilizing the latters RDT 1000 sequence enrichment solution.The companies say that Ambry may add ...
|
|
|
Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation.A global leader for...
|
|
|
Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation.A global leader for...
|
|
|
Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services
/ b3c newswire / Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation.A global...
|
|
|
Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation.A global leader for...
|
|
|
Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
SAN DIEGO, March 17 /PRNewswire/ -- Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing...
|
|
|
Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
SAN DIEGO, March 17 /PRNewswire/ -- Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing...
|
|
|
H. pylori-induced promoter hypermethylation downregulates USF1 and USF2 transcription factor gene expression
Helicobacter pylori infection is associated with the development of gastric adenocarcinoma.Upstream stimulatory factors USF1 and USF2 regulate the transcription of genes related to immune response, cell cycle and cell proliferation. A decrease in their...
|
|
|
Ambry Genetics to Use RainDance Microdroplet PCR Tech in Diagnostics, Genomic Research Services
Ambry Genetics will use RainDance Technologies' microdroplet- based PCR technology as part of its diagnostics and genomics services, the companies said today.Under the partnership, Ambry will incorporate RainDance's RDT 1000 platform into sequence-enrichment...
|
|
|
The sweet potato IbMYB1 gene as a potential visible marker for sweet potato intragenic vector system
MYB transcription factors play important roles in transcriptional regulation of many secondary metabolites including anthocyanins.We cloned the R2R3-MYB type IbMYB1 complementary DNAs from the purple-fleshed sweet potato (Ipomoea batatas L. cv Sinzami) and...
|
|
|
miRNAs' Therapeutic Potential
Scientists Scrutinize Promising Molecules as Potential Drug Targets and Biomarkers Patricia F.Dimond, Ph. click to enlarge Researchers at Mt. Sinai School of Medicine are using artificial miRNA target sites to exploit or modulate endogenous miRNA...
|
|
|
DNA Methylation as a Biomarker for Cardiovascular Disease Risk
Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD).This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood...
|
|
|
miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer
To clarify the role of micro (mi) RNAs in gastric carcinogenesis, we studied the expression and function of miRNAs in gastric carcinoma (GC) cells.Initially, we performed microarray analysis using total RNA from 3 human GC cell lines and noncancerous gastric...
|
|
|
New Predictive ADME/Tox Strategies Reduce Attrition
click to enlarge The formation of data-sharing consortia between big pharma companies and academia has helped decrease attrition.(UCB Pharma) Predictive toxicology tools and safety strategies put in place earlier in the drug-development process are beginning...
|
|
|
miRNAs' Therapeutic Potential
click to enlargeResearchers at are using artificial miRNA target sites to exploit or modulate endogenous miRNA regulation.MicroRNAs (miRNAs) finely regulate gene expression and play an important role in various cellular processes, including cell growth,...
|
|
|
FDA Approves Five-Day Dosing Regimen for Dacogen
New Regimen Offers a New Outpatient Dosing Option for Myelodysplastic Syndromes Tokyo, Japan | March 12, 2010 | Eisai Co., Ltd.(Headquarters: Tokyo, President and CEO: Haruo Naito) announced today that its U.S. subsidiary Eisai Inc. received approval...
|
|
|
Anti-N-methyl-D-aspartate Receptor Encephalitis
_ Anti-N-methyl-D-aspartate Receptor Encephalitis.
|
